Glycogen storage disease due to acid maltase deficiency, late-onset
Glycogen storage disease due to acid maltase deficiency, late-onset
Definition
Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes.
Also known as Alpha-1,4-glucosidase acid deficiency, late onset, Alpha-1,4-glucosidase acid deficiency, late-onset, glycogen storage disease type 2, late onset, glycogen storage disease type 2, late-onset, glycogen storage disease type II, late onset, glycogen storage disease type II, late-onset, glycogenosis type 2, late onset, glycogenosis type 2, late-onset, glycogenosis type II, late onset, glycogenosis type II, late-onset, GSD due to acid maltase deficiency, late onset, GSD due to acid maltase deficiency, late-onset, GSD type 2, late onset, GSD type 2, late-onset, GSD type II, late onset, GSD type II, late-onset, LOPD, Pompe disease, late onset, Pompe disease, late-onset — per MONDO